Compare DCTH & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | TATT |
|---|---|---|
| Founded | 1988 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.4M | 571.4M |
| IPO Year | 2015 | 2002 |
| Metric | DCTH | TATT |
|---|---|---|
| Price | $16.31 | $39.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $22.00 | ★ $57.17 |
| AVG Volume (30 Days) | ★ 686.8K | 127.9K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.53 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.54 | $16.29 |
| Revenue Next Year | $33.15 | $16.09 |
| P/E Ratio | $412.00 | ★ $38.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.12 | $31.52 |
| 52 Week High | $17.42 | $64.50 |
| Indicator | DCTH | TATT |
|---|---|---|
| Relative Strength Index (RSI) | 59.15 | 49.55 |
| Support Level | $9.98 | $37.04 |
| Resistance Level | $17.42 | $41.55 |
| Average True Range (ATR) | 0.45 | 1.44 |
| MACD | -0.19 | 0.08 |
| Stochastic Oscillator | 30.65 | 50.64 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.